Milan District Court Confirms The Validity Of Alfa Wasserman's Rifaximin-Alpha Patents
6/12/2014 8:12:40 AM
BOLOGNA, Italy, June 12, 2014 /PRNewswire via COMTEX/ -- BOLOGNA, Italy, June 12, 2014 /PRNewswire/ --
Normix® is the only authorized Gastrointestinal antibiotic based on Rifaximin-alpha. No generic version is allowed.
With the judgment entered last April 18, the district court of Milan, Italy - the court having origi nal jurisdiction on the matter - denied a request from generic manufacturers to declare Alfa Wassermann ' s patents on R ifaximin polymorphs invalid.
Help employers find you! Check out all the jobs and post your resume.
comments powered by